2023
Brief Report: How Do We Reach Men? Offering HIV Testing in Evenings and Weekends in the HPTN 071 (PopART) Community-Based Trial in South Africa
Yang B, Sloot R, Floyd S, Awoniyi D, Griffith S, Ayles H, Fidler S, Hayes R, Vermund S, Bock P, team H. Brief Report: How Do We Reach Men? Offering HIV Testing in Evenings and Weekends in the HPTN 071 (PopART) Community-Based Trial in South Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2023, 93: 300-304. PMID: 37001128, PMCID: PMC10313787, DOI: 10.1097/qai.0000000000003197.Peer-Reviewed Original ResearchConceptsHIV testingHousehold visitsWeekday shiftsNumber of menCommunity HIV care providersCommunity-based HIV testingHIV care providersHPTN 071 (PopART) trialUnknown HIV statusHigh-burden settingsAntiretroviral treatment coverageCommunity-based trialHigh-risk behaviorsCommunity-based servicesPopART interventionHIV statusHIV epidemicTreatment coverageCare providersLinear regression analysisStudy questionnaireMore menRecruitment of menVisitsWomen
2010
Addressing Research Priorities for Prevention of HIV Infection in the United States
Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, Sadr W. Addressing Research Priorities for Prevention of HIV Infection in the United States. Clinical Infectious Diseases 2010, 50: s149-s155. PMID: 20397942, PMCID: PMC2862583, DOI: 10.1086/651485.Peer-Reviewed Original ResearchConceptsHIV infectionHuman immunodeficiency virusHispanic womenHIV Prevention Trials NetworkNew HIV infectionsClinical Trials GroupName-based reportingHigh rateImmunodeficiency virusAIDS diagnosisTrial groupUS womenInfected personsPrevention estimatesUS populationHealth messagesEthnic minority populationsTrials NetworkDisease controlInfectionWhite womenWomenPreventionNational InstituteMen
2005
Parents’/guardians’ willingness to vaccinate their children against genital herpes
Liddon N, Pulley L, Cockerham WC, Lueschen G, Vermund SH, Hook EW. Parents’/guardians’ willingness to vaccinate their children against genital herpes. Journal Of Adolescent Health 2005, 37: 187-193. PMID: 16109337, DOI: 10.1016/j.jadohealth.2005.05.030.Peer-Reviewed Original ResearchConceptsHSV-2Type 2 vaccineLogistic regression modelsParents/guardiansInfluenza shotSTD vaccinesCorrelates of intentionGenital herpesMajority of parentsVaccine acceptanceDisease vaccineVaccinationLogistic regressionOptimal timingFuture interventionsVaccineAppropriate timingSexual activityTelephone surveyChildrenParents' acceptanceInterventionOne-thirdDescriptive statisticsOverall attitude
1998
The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants
Rogers A, Futterman D, Moscicki A, Wilson C, Ellenberg J, Vermund S. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants. Journal Of Adolescent Health 1998, 22: 300-311. PMID: 9561462, DOI: 10.1016/s1054-139x(97)00279-6.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdolescent Health ServicesCohort StudiesComorbidityData CollectionDisease ProgressionFemaleHealth Planning OrganizationsHIV InfectionsHumansMaleMulticenter Studies as TopicProgram DevelopmentProspective StudiesResearchResearch DesignUnited StatesConceptsAdolescent Medicine HIV/AIDS Research NetworkMedical chart abstractionGroup of HIVHIV-negative controlsAIDS Research NetworkHIV-positive youthLocal institutional review boardInstitutional review boardResearch NetworkREACH projectChart abstractionClinical characteristicsImmunologic profileClinical courseHIV pathogenesisPhysical examinationHIV epidemicStudy populationAdolescent careDisease comorbiditiesClinical experienceMultidisciplinary teamHormonal variationsStudy aimReview board
1994
The role of prevention research in HIV vaccine trials.
Vermund SH. The role of prevention research in HIV vaccine trials. AIDS Research And Human Retroviruses 1994, 10 Suppl 2: s303-5. PMID: 7865326.Peer-Reviewed Original ResearchConceptsVaccine trialsLarge-scale vaccine trialsHIV vaccine efficacy trialsPrevention researchVaccine efficacy trialsHIV vaccine trialsPrevention clinical trialsHIV prevention researchSexual transmissionClinical trialsEfficacy trialsNeedle useHIV researchInfectious diseasesBlood contaminationPotential trial sitesTrialsNational InstituteObservational researchTrial sitesSame criteriaPrevention technologiesAllergyVaccineInfection